Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

How patients in Denmark acquire their medicines: overview, data sources and implications for pharmacoepidemiology

Research output: Contribution to journalReviewpeer-review

DOI

  1. Drug-related challenges following primary total hip and knee arthroplasty

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety

    Research output: Contribution to journalReviewpeer-review

  3. Postponement of cardiovascular outcomes by statin use: A systematic review and meta-analysis of randomized clinical trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. BCPT policy for experimental and clinical studies

    Research output: Contribution to journalEditorialpeer-review

  1. Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Drug-related challenges following primary total hip and knee arthroplasty

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. GLP-1 based therapies and disease course of inflammatory bowel disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998-2018

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The means by which patients acquire their medications differ between countries, and a knowledge of this is essential when conducting and interpreting pharmacoepidemiological studies. The aim of this paper is to provide an overview of how patients obtain medicines in Denmark, to relate these to nationwide registries available for research and to discuss the implications for research. Health services are predominantly tax-funded in Denmark, with dentistry and some medicine bought at community pharmacies being exceptions, involving partial reimbursement of charges. The paper gives an overview of prescription medicines acquired from community pharmacies (including magistral preparations), over-the-counter medicines, vaccinations and in-hospital medicine including so-called "free medicine" (in Danish: "vederlagsfri medicin"). "Free medicine" is medicines for a defined list of diseases and indications that is provided free of charge to patients in outpatient clinics. The paper also describes the content of the various Danish data sources about medicine use, summarizes their strengths and limitations, and exemplifies the ways of evaluating their completeness. An example is provided of the regional variation in the means by which medicines are acquired.

Original languageEnglish
JournalBasic & clinical pharmacology & toxicology
Volume128
Issue number1
Pages (from-to)46-51
Number of pages6
ISSN1742-7843
DOIs
Publication statusPublished - Jan 2021

    Research areas

  • drug prescriptions (MeSH), electronic health records (MeSH), in-hospital drug use, non-prescription drugs (MeSH), pharmacoepidemiology (MeSH)

ID: 61311313